-
2022-502779-40-99
Primary prevention of atherosclerotic cardiovascular di 5
-
2025-520554-11-00
Cardiovascular Disease 5
-
2024-519870-38-00
Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
-
2025-521188-11-00
Type 2 diabetes 5 2025-10-15
-
2024-516652-18-00
Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
-
2024-519059-28-00
Chronic Heart Failure 5 2025-07-17
-
2023-508162-15-00
Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
-
2025-520521-21-00
Hyperlipidemia 5 2025-09-02
-
2022-502779-40-00
Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
-
2022-501419-15-00
Atrial Fibrillation 5 2023-08-23
-
2022-501999-26-00
Severe Hypertriglyceridemia (SHTG) 5 2023-07-12
-
2022-501608-85-00
Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
-
2022-501939-16-00
Heart failure (HF) with mildly reduced ejection fractio 5 2023-05-09
-
2023-507795-51-00
atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
-
2023-508292-37-00
Cardiovascular Disease 5 2020-03-06
-
2023-507640-36-00
Resistant hypertension (rHTN) defined as blood pressure 5 2024-04-29
-
2023-504678-39-00
Heart Failure 4 2024-03-13
-
2023-505499-32-00
Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
-
2023-506197-12-00
Dyslipidemia
Dyslipidemias are alterations to the plasm 4 2024-02-07
-
2022-501418-69-00
Acute Coronary Syndrome 5 2023-11-21
-
2022-503022-13-00
Hypertriglyceridemia, Cardiovascular Diseases, Atherosc 5 2023-06-08
-
2022-501420-20-00
Severe hypertryglyceridemia 5 2023-05-17
-
2023-503794-38-00
Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
-
2023-503673-38-00
Adults at high risk of cardiovascular events without pr 5 2019-05-24